Page last updated: 2024-08-22

stavudine and Hepatitis B, Chronic

stavudine has been researched along with Hepatitis B, Chronic in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belyhun, Y; Liebert, UG; Maier, M	1
Moreno, V; Valencia, ME	1
Emery, S; Hu, Z; Khabo, P; Maja, P; Manzini, P; Matchaba, G; Matthews, GV; Metcalf, J; Orsega, S; Pool, N; Sangweni, P	1

Trials

1 trial(s) available for stavudine and Hepatitis B, Chronic

Article	Year
Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa. AIDS (London, England), 2011, Sep-10, Volume: 25, Issue:14 Topics: Adult; Africa, Southern; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; CD4 Lymphocyte Count; Didanosine; Female; Hepatitis B virus; Hepatitis B, Chronic; HIV-1; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Stavudine; Treatment Outcome	2011

Article

Year

Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa.

AIDS (London, England), 2011, Sep-10, Volume: 25, Issue:14

Topics: Adult; Africa, Southern; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; CD4 Lymphocyte Count; Didanosine; Female; Hepatitis B virus; Hepatitis B, Chronic; HIV-1; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Stavudine; Treatment Outcome

2011

Other Studies

2 other study(ies) available for stavudine and Hepatitis B, Chronic

Article	Year
HIV therapy with unknown HBV status is responsible for higher rate of HBV genome variability in Ethiopia. Antiviral therapy, 2017, Volume: 22, Issue:2 Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Coinfection; Cyclopropanes; DNA, Viral; Drug Resistance, Viral; Ethiopia; Female; Genetic Variation; Genome, Viral; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Infections; Humans; Immune Evasion; Lamivudine; Male; Mutation; Stavudine; Viral Load; Zidovudine	2017
[Atazanavir-induced nephrolithiasis]. Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:2 Topics: Adenine; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis D, Chronic; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Lopinavir; Male; Nephrolithiasis; Oligopeptides; Organophosphonates; Pyridines; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Tenofovir	2009

Article

Year

HIV therapy with unknown HBV status is responsible for higher rate of HBV genome variability in Ethiopia.

Antiviral therapy, 2017, Volume: 22, Issue:2

Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Coinfection; Cyclopropanes; DNA, Viral; Drug Resistance, Viral; Ethiopia; Female; Genetic Variation; Genome, Viral; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Infections; Humans; Immune Evasion; Lamivudine; Male; Mutation; Stavudine; Viral Load; Zidovudine

2017

[Atazanavir-induced nephrolithiasis].

Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:2

Topics: Adenine; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis D, Chronic; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Lopinavir; Male; Nephrolithiasis; Oligopeptides; Organophosphonates; Pyridines; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Tenofovir

2009